Document is current
Any future updates will be listed below
-
Authors
Zhang, Yanyan
Song, Haoqian
Cui, Wenshuai
Peng, Kunwei
-
Funding
Funding for this research was provided by:
Guangzhou Science and Technology Foundation (2023A04J0591)
Plan on enhancing scientific research in GMU (2024)
- License Information
-
More Information
Article History
Received: 12 July 2025
Accepted: 26 September 2025
First Online: 15 October 2025
Declarations
:
: This study was conducted in accordance with the ethical standards of the Institutional Review Board and Ethics Committee of The Second Affiliated Hospital, Guangzhou Medical University. The use of the hepatocellular carcinoma (HCC) tissue microarray was approved by the Ethics Committee of Shanghai Outdo Biotech Company (Ethical Number: SHYJS-CP-1804007). All participants provided informed consent prior to participation in the research. All authors consent to participate.
: All patients signed informed consent forms and agreed to provide clinical data for research purposes. Signed formal consents are available to ensure that the publisher has the authors’ permission to publish the research findings.
: The authors declare no competing interests.
